Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does cholesterol lowering prevent stroke?

R Y Henry1, M J Kendall

  • 1Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK.

Journal of Clinical Pharmacy and Therapeutics
|January 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charles Dickens' favourite child and a new kind of ray.

Journal of clinical pharmacy and therapeutics·2016
Same author

Experimentally simulating high-rate behaviour: rate and temperature effects in polycarbonate and PMMA.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2014
Same author

Mechanics of particulate composites with glassy polymer binders in compression.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2014
Same author

Availability of methaqualone from commercial preparations: in vitro and in vivo studies in man.

British journal of clinical pharmacology·2012
Same author

An assessment of gastric emptying by breathalyser.

British journal of clinical pharmacology·2012
Same author

The influence of diphenhydramine on the absorption of methaqualone in man.

British journal of clinical pharmacology·2012

Lowering plasma cholesterol with HMG-CoA reductase inhibitors (Statins) is proven to reduce coronary events. This review shows Statins also convincingly reduce stroke risk, challenging previous treatment aims.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Lowering plasma cholesterol is crucial for preventing coronary events.
  • Hypertension control has historically been the primary focus for stroke prevention.
  • Lipid-lowering therapy was not previously considered essential for stroke prevention.

Purpose of the Study:

  • To review evidence on the role of lipid-lowering therapy in stroke prevention.
  • To evaluate the impact of HMG-CoA reductase inhibitors (Statins) on stroke risk.

Main Methods:

  • Review of large multicentre trials.
  • Analysis of imaging studies.
  • Synthesis of meta-analyses data.

Main Results:

Related Experiment Videos

  • Statins significantly reduce the risk of stroke.
  • Evidence supports the efficacy of Statins beyond coronary event prevention.

Conclusions:

  • HMG-CoA reductase inhibitors (Statins) are effective in reducing stroke risk.
  • Lipid-lowering therapy should be considered in stroke prevention strategies.